Cell Surface Markers 2011: US, Europe, Japan Forecasts by Test, Market Segment and Country

News provided by

Aug 08, 2011, 04:27 ET

NEW YORK, Aug. 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0365379/Cell-Surface-Markers-2011-US-Europe-Japan-Forecasts-by-Test-Market-Segment-and-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next ten years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.

The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 120 pages and 15 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

A. Lymphocyte Subclassification CD4/CD8/CD34

° Instrumentation and

Reagent Test Kits

* BD FACS Count

* Beckman Coulter VCS

* T Cells Diagnostics TRAx

B. Other Cell Markers

C. Instrumentation Review

1. Hematology Analyzers

a. Overview

° Electrical Aperture-Impedance

Analyzers

° Light Scatter Analyzers

b. System Review

° Abbott Cell-Dyn 3000

° Abbott Cell-Dyn 3200

° Abbott Cell-Dyn 3500

° Abbott Cell-Dyn 3700

° Abbott Cell-Dyn Ruby

° Abbott Cell-Dyn Sapphire

° Abbott Cell-Dyn Emerald

° Beckman Coulter HmX

° Beckman Coulter LH 500

° Beckman Coulter LH 750

° Beckman Coulter LH 780

° Beckman Coulter LH 1500

° Beckman Coulter STKS

° Beckman Coulter UniCell DxH 800

° Horiba ABX Helios LMG/5DIFF

° Horiba ABX Pentra Series

° Siemens ADVIA/H Series

° Siemens Advia 120

° Siemens Advia 2120i

° Sysmex XE-2100

° Sysmex XE-5000

° Sysmex XE-AlphaN

° Sysmex HST-N

° Sysmex NE-8000

° Sysmex SE-9000

° Sysmex XT Series

2. Flow Cytometers

a. Introduction

b. System Overview

° Beckman Coulter Epics Profile

° Beckman Coulter Epics XL

° BD FACSadvantage

° BD FACSAria III

° BD FACScan

° BD FACSCanto II

° BD FACSCalibur

° BD FACSCount

° BD Influx

° BD FACStar Series

° BD FACSort

° BD FACStrak

° BD FACS Vantage

° Beckman Coulter Epics Elite ESP

° Beckman Coulter Epics Elite Analyzer

° Beckman Coulter Epics C

° Beckman Coulter FC 500 Series

° Beckman Coulter Vi-CELL XR

D. Current Market Needs and Future Demand for

Hematology Analyzers

E. Reagents and Controls

F. Current and Emerging Technologies

1. Information Technologies

2. Automation and Robotics

3. Lasers

4. Artificial Intelligence

5. Monoclonal Antibodies

6. Molecular Diagnostics

7. Microdrop Technology

III. France : Forecasts by Test and Market Segment

IV. Germany : Forecasts by Test and Market Segment

V. Italy : Forecasts by Test and Market Segment

VI. Japan : Forecasts by Test and Market Segment

VII. Spain : Forecasts by Test and Market Segment

VIII. U.K. : Forecasts by Test and Market Segment

IX. U.S. : Forecasts by Test and Market Segment

X. Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for the Decentralized

Testing Markets

1. Four Marketing Approaches

2. Product Complexity Factor

3. Customer Preference Factor

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation Factor

XI. Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

XII. Competitive Assessments

° Abbott

° Beckman Coulter

° Becton Dickinson

° Bio-Rad

° DakoCytomation

° Horiba

° Iris

° J&J Diagnostics

° Nihon Kohden

° Roche

° Siemens

° Sysmex

XIII. Appendix: Major Universities and Research

Centers Developing Hematology/Flow Cytometry

Technologies and Applications

List of Tables

France, Hospital Laboratories Estimated